- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1109EUR$1,250USD£958GBP
- Report
- August 2025
- 183 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- August 2025
- 180 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- May 2025
- 186 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- May 2025
- 185 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- April 2025
- 184 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- February 2025
- 185 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- February 2025
- 184 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Report
- January 2025
- 182 Pages
Global
From €3994EUR$4,500USD£3,451GBP
- Clinical Trials
- July 2025
- 80 Pages
Global
From €1775EUR$2,000USD£1,534GBP
- Report
- August 2025
- 150 Pages
Global
From €2980EUR$3,358USD£2,574GBP
€3506EUR$3,950USD£3,029GBP
- Report
- May 2025
- 106 Pages
Global
From €4216EUR$4,750USD£3,642GBP
- Report
- June 2025
- 138 Pages
Global
From €2805EUR$3,160USD£2,423GBP
€3506EUR$3,950USD£3,029GBP
- Report
- January 2025
- 140 Pages
Global
From €2805EUR$3,160USD£2,423GBP
€3506EUR$3,950USD£3,029GBP
- Report
- December 2024
- 144 Pages
Global
From €2805EUR$3,160USD£2,423GBP
€3506EUR$3,950USD£3,029GBP
- Report
- February 2025
- 221 Pages
Global
From €2219EUR$2,500USD£1,917GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2475EUR$2,789USD£2,139GBP
- Report
- July 2025
- 350 Pages
Global
From €4392EUR$4,949USD£3,795GBP
- Report
- June 2025
- 150 Pages
Global
From €2395EUR$2,699USD£2,070GBP
- Report
- June 2025
- 150 Pages
Global
From €2395EUR$2,699USD£2,070GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more